Press Release Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 2 hours ago
Press Release Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026 Aug 4